New York Life Investment Management LLC Alnylam Pharmaceuticals, Inc. Transaction History
New York Life Investment Management LLC
- $9.63 Billion
- Q3 2024
A detailed history of New York Life Investment Management LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, New York Life Investment Management LLC holds 2,231 shares of ALNY stock, worth $605,292. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,231
Previous 2,263
1.41%
Holding current value
$605,292
Previous $549,000
11.66%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding ALNY
# of Institutions
650Shares Held
109MCall Options Held
1.28MPut Options Held
1.23M-
Capital World Investors Los Angeles, CA16.5MShares$4.48 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$3.43 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.59 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.42 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.34 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.4B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...